Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Alpha Cognition Inc ACOGF


Primary Symbol: C.ACOG

Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062 is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.


CSE:ACOG - Post by User

Post by partystockeron Jan 20, 2022 3:30pm
114 Views
Post# 34338933

Shares of $ACOG...

Shares of $ACOG...

Shares of Alpha Cognition $ACOG $ACOG.V are reaching a crucial point where a big jump in volume could send shares on a huge run. 


With price action continuing along with a descending triangle pattern, the day shares will see a breakout from the pattern is getting closer and closer. At this point, the latest a breakout could occur is in the first week of February. 

With shares having tested prices at $1.86 previously, I’m expecting to see a retest should $ACOG break above the pattern. At current price levels that marks a 68% gain. 


I’ll be expecting news regarding the progress of the company's therapies for Alzheimers and ALS to provide the strongest bullish catalyst.


SHares of $ACOG are currently trading at $1.10 and the company is valued at an MCAP of $67.65 million. 


https://www.alphacognition.com/

 
<< Previous
Bullboard Posts
Next >>